Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV-Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial.

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/39509

Title:	Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV-Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial.
Authors:	Baker, Jason V Sharma, Shweta Achhra, Amit C Bernardino, Jose Ignacio Bogner, Johannes R Duprez, Daniel Emery, Sean Gazzard, Brian Gordin, Jonathan Grandits, Greg Phillips, Andrew N Schwarze, Siegfried Soliman, Elsayed Z Spector, Stephen A Tambussi, Giuseppe Lundgren, Jens View more
Keywords:	HIV antiretroviral therapy cholesterol risk factor View more
Mesh:	Adult Anti-HIV Agents Cardiovascular Diseases Comorbidity Cyclic N-Oxides Drug Administration Schedule Female Follow-Up Studies Global Health HIV Infections Humans Male Mercaptoethanol Risk Factors Time Factors HIV Risk Assessment View more
Issue Date:	22-May-2017
Citation:	J Am Heart Assoc.2017 May;(6)5:
Abstract:	HIV infection and certain antiretroviral therapy (ART) medications increase atherosclerotic cardiovascular disease risk, mediated, in part, through traditional cardiovascular disease risk factors.
PMID:	28533305
URI:	https://hdl.handle.net/20.500.12530/39509
Rights:	openAccess
Appears in Collections:	Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos

Files in This Item:

File	Description	Size	Format
PMC5524070.pdf		949.04 kB	Adobe PDF	View/Open